- No mention of a minimum cap.
- They will review 100-200 companies and narrow this down.
- Focuses on companies developing cutting-edge therapies and technologies
- 20% Healthcare tech/AI/Software & 80% Biotech/medical devices/diagnostics
- Pre Clinical (10%), Phase 1 (10/20%), Phase 2/3 (25/35%), Commercial Stage (40/50%)
- Mentions they may invest up to a third of capital into micro/small cap listed
- No mention of a minimum cap.- They will review 100-200...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $70.51K | 318.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 135215 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 146568 | 6 |
View Market Depth
| Last trade - 11.14am 04/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |